PRA Health Sciences, Inc. – NASDAQ:PRAH

PRA Health Sciences stock price today

$165.21
Financial Health
0
1
2
3
4
5
6
7
8
9

PRA Health Sciences stock price monthly change

-3.10%
month

PRA Health Sciences stock price quarterly change

+5.79%
quarter

PRA Health Sciences stock price yearly change

+74.05%
year

PRA Health Sciences key metrics

Market Cap
1
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
3.35
Revenue
3.33B
EBITDA
444.89M
Income
213.32M
Revenue Q/Q
19.14%
Revenue Y/Y
6.56%
Profit margin
6.4%
Oper. margin
8.69%
Gross margin
27.12%
EBIT margin
8.69%
EBITDA margin
13.35%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

PRA Health Sciences stock price history

PRA Health Sciences stock forecast

PRA Health Sciences financial statements

PRA Health Sciences, Inc. (NASDAQ:PRAH): Profit margin
Jun 2020 729.89M 13.87M 1.9%
Sep 2020 796.30M 91.25M 11.46%
Dec 2020 873.45M 51.25M 5.87%
Mar 2021 933.77M 56.94M 6.1%
PRA Health Sciences, Inc. (NASDAQ:PRAH): Earnings per share (EPS)
2020-08-06 0.83 0.86
2020-11-04 1.12 1.3
2021-02-24 1.47 1.55
2021-04-28 1.34 1.35
PRA Health Sciences, Inc. (NASDAQ:PRAH): Debt to assets
Jun 2020 3722801000 2.55B 68.64%
Sep 2020 3839214000 2.51B 65.48%
Dec 2020 4178501000 2.69B 64.6%
Mar 2021 4282745000 2.72B 63.66%
PRA Health Sciences, Inc. (NASDAQ:PRAH): Cash Flow
Jun 2020 25.88M -19.53M 9.42M
Sep 2020 180.63M -18.40M 4.90M
Dec 2020 160.07M -14.66M 21.90M
Mar 2021 192.20M -18.73M 12.04M

PRA Health Sciences other data

PRA Health Sciences, Inc. (NASDAQ:PRAH): Insider trades (number of shares)
Period Buy Sel
Aug 2020 0 9489
Dec 2020 0 33372
Jan 2021 0 3136
Apr 2021 0 2048
Jun 2021 0 1638541
Transaction Date Insider Security Shares Price per share Total value Source
Option
SHANNON COLIN director, officer: President & ..
Common Stock 442,241 N/A N/A
Sale
SHANNON COLIN director, officer: President & ..
Common Stock 442,241 N/A N/A
Option
SHANNON COLIN director, officer: President & ..
Stock Option (Right to Buy) 276,205 N/A N/A
Option
BONELLO MICHAEL J. officer: EVP & CFO
Common Stock 52,551 $93.62 $4,919,667
Sale
BONELLO MICHAEL J. officer: EVP & CFO
Common Stock 52,551 $168.4 $8,849,483
Option
BONELLO MICHAEL J. officer: EVP & CFO
Stock Options (Right to Buy) 52,551 $93.62 $4,919,667
Option
GAENZLE CHRISTOPHER L officer: EVP, CAO & General Cou..
Common Stock 27,497 $100.22 $2,755,749
Sale
GAENZLE CHRISTOPHER L officer: EVP, CAO & General Cou..
Common Stock 27,497 $168.66 $4,637,507
Option
GAENZLE CHRISTOPHER L officer: EVP, CAO & General Cou..
Stock Options (Right to Buy) 27,497 $100.22 $2,755,749
Option
GAENZLE CHRISTOPHER L officer: EVP, CAO & General Cou..
Stock Options (Right to Buy) 27,497 $100.22 $2,755,749
Patent
Application
Filling date: 14 Jul 2020 Issue date: 7 Jan 2021
  • What's the price of PRA Health Sciences stock today?

    One share of PRA Health Sciences stock can currently be purchased for approximately $165.21.

  • When is PRA Health Sciences's next earnings date?

    Unfortunately, PRA Health Sciences's (PRAH) next earnings date is currently unknown.

  • Does PRA Health Sciences pay dividends?

    No, PRA Health Sciences does not pay dividends.

  • How much money does PRA Health Sciences make?

    PRA Health Sciences has a market capitalization of 1 and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.82% to 3.18B US dollars. PRA Health Sciences earned 197.04M US dollars in net income (profit) last year or $1.35 on an earnings per share basis.

  • What is PRA Health Sciences's stock symbol?

    PRA Health Sciences, Inc. is traded on the NASDAQ under the ticker symbol "PRAH".

  • What is PRA Health Sciences's primary industry?

    Company operates in the Healthcare sector and Diagnostics & Research industry.

  • How do i buy shares of PRA Health Sciences?

    Shares of PRA Health Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does PRA Health Sciences have?

    PRA Health Sciences, Inc. employs 18,100 workers.

  • When PRA Health Sciences went public?

    PRA Health Sciences, Inc. is publicly traded company for more then 10 years since IPO on 13 Nov 2014.

  • What is PRA Health Sciences's official website?

    The official website for PRA Health Sciences is prahs.com.

  • Where are PRA Health Sciences's headquarters?

    PRA Health Sciences is headquartered at 4130 Parklake Ave Ste 400, Raleigh, NORTH CAROLINA.

  • How can i contact PRA Health Sciences?

    PRA Health Sciences's mailing address is 4130 Parklake Ave Ste 400, Raleigh, NORTH CAROLINA and company can be reached via phone at +1 919 786 8200.

PRA Health Sciences company profile:

PRA Health Sciences, Inc.

prahs.com
Exchange:

NASDAQ

Full time employees:

18,100

Industry:

Diagnostics & Research

Sector:

Healthcare

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company has a partnership with The Leukemia & Lymphoma Society to launch a clinical trial for developing treatments for children with relapsed acute leukemia. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.

4130 Parklake Ave Ste 400
Raleigh, NORTH CAROLINA 27612

CIK: 0001613859
ISIN: US69354M1080
CUSIP: 69354M108